Immunogenomic pathways associated with cytotoxic lymphocyte infiltration and survival in colorectal cancer

BACKGROUND: Colorectal cancer (CRC) is the second leading cancer killer in the US today and patients with metastatic disease have only a 14% 5-year survival. One of the most impactful recent advances in cancer therapy, immune checkpoint inhibition, has not been shown to be effective for the majority...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yuanyuan, Guan, Yue, Hummel, Justin J., Shyu, Chi-Ren, Mitchem, Jonathan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023815/
https://www.ncbi.nlm.nih.gov/pubmed/32059711
http://dx.doi.org/10.1186/s12885-020-6513-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023815/
https://www.ncbi.nlm.nih.gov/pubmed/32059711
http://dx.doi.org/10.1186/s12885-020-6513-4

Ejemplares similares